Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Archives of Gynecology and Obstetrics
|
November 19, 2004
Study of abdominal circumference proportions in fetuses with growth disorders
José Morales-Roselló, Maria Teresa León-Mendoza
BMC Genomics
|
July 10, 2026
D3aist: data-driven detection of atypical interactions in spatial transcriptomics
Teresa León, Juan Domingo, Guillermo Ayala, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
November 1, 2008
Analyzing protein-protein spatial-temporal dependencies from image sequences using fuzzy temporal random sets
María Elena Díaz, Guillermo Ayala, Teresa León, et al.
Plos One
|
November 21, 2013
Numerical capacities as domain-specific predictors beyond early mathematics learning: a longitudinal study
Vivian Reigosa-Crespo, Eduardo González-Alemañy, Teresa León, et al.
Revista Espanola De Geriatria Y Gerontologia
|
February 25, 2009
[Prevalence of dementia in institutionalized patients. The RESYDEM study]
Rosa López Mongil, J Antonio López Trigo, F Javier Castrodeza Sanz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 4, 2014
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
Günter U Höglinger, Hans-Jürgen Huppertz, Stefan Wagenpfeil, et al.
Alzheimer'S Research & Therapy
|
January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease
Jeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 18, 2014
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa, Irene Litvan, Günter U Höglinger, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 14, 2025
Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
Krista Lanctot, Linus Jönsson, Alireza Atri, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 3, 2025
Alzheimer's disease drug development in an evolving therapeutic landscape
Stacie Weninger, Michael C Irizarry, Adam S Fleisher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Archives of Gynecology and Obstetrics
|
November 19, 2004
Study of abdominal circumference proportions in fetuses with growth disorders
José Morales-Roselló, Maria Teresa León-Mendoza
BMC Genomics
|
July 10, 2026
D3aist: data-driven detection of atypical interactions in spatial transcriptomics
Teresa León, Juan Domingo, Guillermo Ayala, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
November 1, 2008
Analyzing protein-protein spatial-temporal dependencies from image sequences using fuzzy temporal random sets
María Elena Díaz, Guillermo Ayala, Teresa León, et al.
Plos One
|
November 21, 2013
Numerical capacities as domain-specific predictors beyond early mathematics learning: a longitudinal study
Vivian Reigosa-Crespo, Eduardo González-Alemañy, Teresa León, et al.
Revista Espanola De Geriatria Y Gerontologia
|
February 25, 2009
[Prevalence of dementia in institutionalized patients. The RESYDEM study]
Rosa López Mongil, J Antonio López Trigo, F Javier Castrodeza Sanz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 4, 2014
Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
Günter U Höglinger, Hans-Jürgen Huppertz, Stefan Wagenpfeil, et al.
Alzheimer'S Research & Therapy
|
January 9, 2025
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease
Jeffrey L Cummings, Alireza Atri, Howard H Feldman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 18, 2014
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Eduardo Tolosa, Irene Litvan, Günter U Höglinger, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
April 14, 2025
Measuring time saved in Alzheimer's disease: What is a meaningful slowing of progression?
Krista Lanctot, Linus Jönsson, Alireza Atri, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
January 3, 2025
Alzheimer's disease drug development in an evolving therapeutic landscape
Stacie Weninger, Michael C Irizarry, Adam S Fleisher, et al.
Page
of 2